Top

09-02-2025

Predicting antiretroviral medication adherence among substance-using people with HIV: test and extension of the information-motivation-behavioral skills model

Auteurs: Archana Krishnan, Yerina S. Ranjit, Xin Zhou, Frederick L. Altice

Gepubliceerd in: Journal of Behavioral Medicine

Abstract

Antiretroviral therapy (ART) is effective in reducing HIV transmission and mortality, yet daily adherence remains a challenge for many people with HIV (PWH). Suboptimal adherence can lead to virological failure and increased mortality, particularly among those with substance use disorders, such as cocaine use disorder (CUD). The Information-Motivation-Behavioral (IMB) skills model offers a framework to understand and enhance ART adherence by addressing individual and social barriers. In this study, we tested the IMB skills model among 80 cocaine-using PWH currently on ART, and found that behavioral skills significantly predicted adherence. In the extension of the IMB skills model, the addition of practical barriers altered the relationship by showing that motivational barriers such as treatment fatigue and practical barriers significantly affected ART adherence. The findings suggest that for PWH with substance use disorders, addressing practical barriers and motivational factors may be crucial for improving ART adherence, in addition to building behavioral skills.

Altice, F. L., & Friedland, G. H. (1998). The era of adherence to HIV therapy. Annals of Internal Medicine, 129(6), 503–505.CrossRefPubMed

Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367–387. http://linkinghub.elsevier.com/retrieve/pii/S014067361060829XCrossRef

Amico, K. R., Barta, W., Konkle-Parker, D. J., Fisher, J. D., Cornman, D. H., Shuper, P. A., & Fisher, W. A. (2009a). The information-motivation-behavioral skills model of ART adherence in a Deep South HIV + clinic sample [Research support, N.I.H., Extramural]. Aids and Behavior, 13(1), 66–75. https://doi.org/10.1007/s10461-007-9311-yCrossRefPubMed

Amico, K. R., Barta, W., Konkle-Parker, D. J., Fisher, J. D., Cornman, D. H., Shuper, P. A., & Fisher, W. A. (2009b). The information–motivation–behavioral skills model of ART adherence in a deep south HIV + clinic sample. AIDS and Behavior, 13(1), 66–75.CrossRefPubMed

Anand, P., Springer, S. A., Copenhaver, M. M., & Altice, F. L. (2010). Neurocognitive impairment and HIV risk factors: A reciprocal relationship. Aids and Behavior, 14(6), 1213–1226. https://doi.org/10.1007/s10461-010-9684-1CrossRefPubMedPubMedCentral

Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381. http://www.ncbi.nlm.nih.gov/pubmed/12047736CrossRefPubMedPubMedCentral

Bae, J. W., Guyer, W., Grimm, K., & Altice, F. L. (2011). Medication persistence in the treatment of HIV infection: A review of the literature and implications for future clinical care and research. Aids (London, England), 25(3), 279–290. https://doi.org/10.1097/QAD.0b013e328340feb0CrossRefPubMed

Bartlett, J. A., Fath, M. J., Demasi, R., Hermes, A., Quinn, J., Mondou, E., & Rousseau, F. (2006). An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. Aids (London, England), 20(16), 2051–2064. https://doi.org/10.1097/01.aids.0000247578.08449.ffCrossRefPubMed

Byrne, B. M. (2013). Structural equation modeling with EQS: Basic concepts, applications, and programming. Routledge.

Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(2), 124–133. https://doi.org/10.1037/0278-6133.19.2.124CrossRefPubMed

Chew, L. D., Bradley, K. A., & Boyko, E. J. (2004). Brief questions to identify patients with inadequate health literacy. Family Medicine, 36(8), 588–594. http://www.ncbi.nlm.nih.gov/pubmed/15343421PubMed

Claborn, K., Becker, S., Operario, D., Safren, S., Rich, J. D., & Ramsey, S. (2018). Adherence intervention for HIV-infected persons who use drugs: Adaptation, open trial, and pilot randomized hybrid type 1 trial protocol. Addiction Science & Clinical Practice, 13(1), 12. https://doi.org/10.1186/s13722-018-0113-5CrossRef

Clifford, D. B., & Ances, B. M. (2013). HIV-associated neurocognitive disorder. The Lancet Infectious Diseases, 13(11), 976–986.CrossRefPubMedPubMedCentral

Cook, J. A., Burke-Miller, J. K., Cohen, M. H., Cook, R. L., Vlahov, D., Wilson, T. E., Golub, E. T., Schwartz, R. M., Howard, A. A., Ponath, C., Plankey, M. W., Levine, A. M., & Grey, D. D. (2008). Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. Aids (London, England), 22(11), 1355–1363. https://doi.org/10.1097/QAD.0b013e32830507f2CrossRefPubMed

Crisp, B. R., Williams, M., Timpson, S., & Ross, M. W. (2004). Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. Aids and Behavior, 8(2), 199–206. https://doi.org/10.1023/B:AIBE.0000030250.33931.afCrossRefPubMed

Cunningham, C. O., Sohler, N. L., Berg, K. M., Shapiro, S., & Heller, D. (2006). Type of substance use and access to HIV-related health care. AIDS Patient Care STDS, 20(6), 399–407. https://doi.org/10.1089/apc.2006.20.399CrossRefPubMed

Feaster, D. J., Mitrani, V. B., Burns, M. J., McCabe, B. E., Brincks, A. M., Rodriguez, A. E., Asthana, D., & Robbins, M. S. (2010). A randomized controlled trial of Structural ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention. Drug and Alcohol Dependence, 111(3), 227–234. https://doi.org/10.1016/j.drugalcdep.2010.04.017CrossRefPubMedPubMedCentral

Ferro, E. G., Culbert, G. J., Wickersham, J. A., Marcus, R., Steffen, A. D., Pauls, H. A., Westergaard, R. P., Lee, C. K., Kamarulzaman, A., & Altice, F. L. (2017). Physician decisions to defer antiretroviral therapy in key populations: Implications for reducing human immunodeficiency virus incidence and mortality in Malaysia. Open Forum Infect Dis, 4(1), ofw219. https://doi.org/10.1093/ofid/ofw219CrossRefPubMedPubMedCentral

Fisher, J. D., Fisher, W. A., Amico, K. R., & Harman, J. J. (2006). An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychology, 25(4), 462.CrossRefPubMed

Gonzalez, A., Barinas, J., & O’Cleirigh, C. (2011). Substance use: Impact on adherence and HIV medical treatment. Current Hiv/Aids Reports, 8(4), 223.CrossRefPubMed

Grella, C. E., Anglin, M. D., & Wugalter, S. E. (1997). Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. American Journal of Drug and Alcohol Abuse, 23(1), 15–42. http://www.ncbi.nlm.nih.gov/pubmed/9048145CrossRefPubMed

Hammond, R., & Harry, T. C. (2008). Efficacy of antiretroviral therapy in Africa: Effect on immunological and virological outcome measures -- a meta-analysis. International Journal of Std and Aids, 19(5), 291–296. https://doi.org/10.1258/ijsa.2007.007248CrossRefPubMed

Horvath, K. J., Carrico, A. W., Simoni, J., Boyer, E. W., Amico, K. R., & Petroll, A. E. (2013). Engagement in HIV medical care and technology use among stimulant-using and nonstimulant‐using men who have sex with men. AIDS Res Treat, 2013(1), 121352.PubMedPubMedCentral

Horvath, K. J., Smolenski, D., & Amico, K. R. (2014). An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. Aids Care, 26(2), 142–151.CrossRefPubMed

Ing, E. C., Bae, J. W., Maru, D. S., & Altice, F. L. (2011). Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy. AIDS and Behavior. https://doi.org/10.1007/s10461-011-0082-0CrossRef

Ingersoll, K. S., Farrell-Carnahan, L., Cohen-Filipic, J., Heckman, C. J., Ceperich, S. D., Hettema, J., & Marzani-Nissen, G. (2011). A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV + crack cocaine users. Drug and Alcohol Dependence, 116(1–3), 177–187. https://doi.org/10.1016/j.drugalcdep.2010.12.016CrossRefPubMedPubMedCentral

Kalichman, S. C., Catz, S., & Ramachandran, B. (1999). Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. Journal of the National Medical Association, 91(8), 439–446.PubMedPubMedCentral

King, K., Horne, R., Cooper, V., Glendinning, E., Michie, S., & Chalder, T. (2022). The development of an intervention to support uptake and adherence to antiretroviral therapy in people living with HIV: The SUPA intervention. A brief report. Transl Behav Med, 12(1). https://doi.org/10.1093/tbm/ibab104

Krüsi, A., Wood, E., Montaner, J., & Kerr, T. (2010). Social and structural determinants of HAART access and adherence among injection drug users. International Journal of Drug Policy, 21(1), 4–9.CrossRefPubMed

Lai, H. H., Kuo, Y. C., Kuo, C. J., Lai, Y. J., Chen, M., Chen, Y. T., Chen, C. C., Yen, M. Y., Hu, B. S., & Wang, T. H. (2020). Methamphetamine use associated with non-adherence to antiretroviral treatment in men who have sex with men. Scientific Reports, 10(1), 1–8.CrossRef

Logan, T. K., & Leukefeld, C. (2000). Sexual and drug use behaviors among female crack users: A multi-site sample. Drug and Alcohol Dependence, 58(3), 237–245. http://www.ncbi.nlm.nih.gov/pubmed/10759034CrossRefPubMed

Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27(3), 251–259. http://www.ncbi.nlm.nih.gov/pubmed/11464144CrossRefPubMed

Lucas, G. M., Griswold, M., Gebo, K. A., Keruly, J., Chaisson, R. E., & Moore, R. D. (2006). Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy. American Journal of Epidemiology, 163(5), 412–420.CrossRefPubMed

Malta, M., Magnanini, M. M., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. Aids and Behavior, 14(4), 731–747. https://doi.org/10.1007/s10461-008-9489-7CrossRefPubMed

Menéndez-Arias, L., & Delgado, R. (2022). Update and latest advances in antiretroviral therapy. Trends in Pharmacological Sciences, 43(1), 16–29.CrossRefPubMed

Menza, T. W., Hixson, L. K., Lipira, L., & Drach, L. (2021). Social determinants of health and care outcomes among people with HIV in the United States. Open Forum Infectious Diseases.

Morgan, E. E., Iudicello, J. E., Cattie, J. E., Blackstone, K., Grant, I., Woods, S. P., & Group, H. N. R. P (2015). Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection. AIDS and Behavior, 19, 166–177.CrossRefPubMedPubMedCentral

Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., & Bangsberg, D. R. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39(8), 1190–1198. https://doi.org/10.1086/424008CrossRefPubMed

Palepu, A., Milloy, M. J., Kerr, T., Zhang, R., & Wood, E. (2011). Homelessness and adherence to antiretroviral therapy among a cohort of HIV-Infected injection drug users. Journal of Urban Health, 88(3), 545–555. https://doi.org/10.1007/s11524-011-9562-9CrossRefPubMedPubMedCentral

Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306CrossRef

Rongkavilit, C., Naar-King, S., Kaljee, L. M., Panthong, A., Koken, J. A., Bunupuradah, T., & Parsons, J. T. (2010). Applying the information-motivation-behavioral skills model in medication adherence among Thai youth living with HIV: A qualitative study. AIDS Patient Care and STDs, 24(12), 787–794. https://doi.org/10.1089/apc.2010.0069CrossRefPubMedPubMedCentral

Sauceda, J. A., Neilands, T. B., Johnson, M. O., & Saberi, P. (2018). An update on the barriers to adherence and a definition of self-report non-adherence given advancements in antiretroviral therapy (ART). Aids and Behavior, 22(3), 939–947.CrossRefPubMedPubMedCentral

Schaecher, K. L. (2013). The importance of treatment adherence in HIV. The American Journal of Managed care, 19(12 Suppl), s231–237.PubMed

Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam-Evans, L. D., & Fleming, P. L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29(2), 117–127. http://www.ncbi.nlm.nih.gov/pubmed/15065731CrossRefPubMed

Sohler, N. L., Wong, M. D., Cunningham, W. E., Cabral, H., Drainoni, M. L., & Cunningham, C. O. (2007). Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care STDS, 21(Suppl 1), S68–76. https://doi.org/10.1089/apc.2007.9985CrossRefPubMed

Sprague, C., & Simon, S. E. (2021). Ending HIV in the USA: Integrating social determinants of health. The Lancet, 398(10302), 742–743.CrossRef

Starace, F., Massa, A., Amico, K. R., & Fisher, J. D. (2006). Adherence to antiretroviral therapy: An empirical test of the information-motivation-behavioral skills model. Health Psychology, 25(2), 153–162. https://doi.org/10.1037/0278-6133.25.2.153CrossRefPubMed

Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., Beckwith, C. G., Dowshen, N., Gordon, C. M., Horn, T., Kumar, P., Scott, J. D., Stirratt, M. J., Remien, R. H., Simoni, J. M., & Nachega, J. B. (2012). Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: Evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Annals of Internal Medicine, 156(11), 817–833. https://doi.org/10.7326/0003-4819-156-11-201206050-00419CrossRefPubMedPubMedCentral

Wechsberg, W. M., Golin, C., El-Bassel, N., Hopkins, J., & Zule, W. (2012). Current interventions to reduce sexual risk behaviors and crack cocaine use among HIV-infected individuals [Research Support, N.I.H., Extramural]. Current Hiv/Aids Reports, 9(4), 385–393. https://doi.org/10.1007/s11904-012-0131-yCrossRefPubMedPubMedCentral

Westergaard, R. P., Ambrose, B. K., Mehta, S. H., & Kirk, G. D. (2012). Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: A survey of north American HIV providers. Journal of the International Aids Society, 15(1), 10. https://doi.org/10.1186/1758-2652-15-10CrossRefPubMedPubMedCentral

Wilson, T., & DeHovitz, J. A. (1997). STDs, HIV, and crack cocaine: A review. AIDS Patient Care STDS, 11(2), 62–66. http://www.ncbi.nlm.nih.gov/pubmed/11361764CrossRefPubMed

Wood, E., Kerr, T., Tyndall, M. W., & Montaner, J. S. (2008). A review of barriers and facilitators of HIV treatment among injection drug users. Aids (London, England), 22(11), 1247–1256.CrossRefPubMed

Titel: Predicting antiretroviral medication adherence among substance-using people with HIV: test and extension of the information-motivation-behavioral skills model
Auteurs: Archana Krishnan
Yerina S. Ranjit
Xin Zhou
Frederick L. Altice
Publicatiedatum: 09-02-2025
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-025-00557-y

Bohn Stafleu van Loghum

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Registreer

Login

Predicting antiretroviral medication adherence among substance-using people with HIV: test and extension of the information-motivation-behavioral skills model

Abstract

Bohn Stafleu van Loghum

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Registreer

Login

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen